1. Home
  2. BNED vs GLSI Comparison

BNED vs GLSI Comparison

Compare BNED & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$9.00

Market Cap

284.0M

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$27.63

Market Cap

327.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
GLSI
Founded
1965
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.0M
327.2M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
BNED
GLSI
Price
$9.00
$27.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
224.7K
116.6K
Earning Date
03-10-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.39
N/A
Revenue
$1,610,170,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$7.78
52 Week High
$12.19
$34.10

Technical Indicators

Market Signals
Indicator
BNED
GLSI
Relative Strength Index (RSI) 34.94 61.75
Support Level $8.90 $21.21
Resistance Level $9.53 $30.08
Average True Range (ATR) 0.49 1.76
MACD -0.19 0.49
Stochastic Oscillator 8.06 81.15

Price Performance

Historical Comparison
BNED
GLSI

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: